Industry: Chemical & Material
Published Date: 2026-04-16
Pages: 136 Pages
Report ld: 6456711
Request Sample
Customized Report
Paracetamol and Acetaminophen API Market Size(US$)

CAGR 2026-2032
1.5%
Market Size,2032
USD 1,065
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Paracetamol and Acetaminophen API market size was US$ 962 million in 2025 and is forecast to reach a readjusted size of US$ 1065 million by 2032 with a CAGR of 1.5% during the forecast period 2026-2032.
Paracetamol API refers to the key active ingredient used in the production of various antipyretic and analgesic preparations; it is a pharmaceutical-grade intermediate product with the chemical name paracetamol. This API typically exists in high-purity powder form and is prepared through chemical synthesis. It possesses pharmacological effects such as reducing fever and relieving mild to moderate pain (e.g., headache, muscle pain, fever from colds). In the industry chain, paracetamol API belongs to the upstream segment and requires further processing (such as tableting, formulation into oral liquids or capsules) to become the final drug product, widely used in the pharmaceutical and consumer health fields.
In recent years, with the continuous improvement of global public health systems and the sustained growth of basic medical needs, paracetamol (acetaminophen), as one of the most widely used antipyretic and analgesic raw materials, has maintained stable market demand. This product is widely used in cold medicines, antipyretics, and analgesics, holding an irreplaceable and important position in the global pharmaceutical consumption system. Against the backdrop of population growth, improved healthcare accessibility, and increased self-medication needs, the paracetamol raw material market has shown a steady upward trend.
From a demand structure perspective, paracetamol raw materials are mainly used in the production of tablets, capsules, oral liquids, and granules, occupying a core position in antipyretic and analgesic drugs and compound cold medicines. With the cyclical occurrence of seasonal influenza and respiratory diseases, the demand for these basic drugs remains constant. At the same time, the growth in demand for pediatric drugs and compound preparations further drives the expansion of the raw material market. In emerging markets, the increasing penetration rate of basic medicines provides continuous incremental growth to the market.
In terms of product structure, pharmaceutical-grade high-purity raw materials are the mainstream in the market, and the products are usually supplied to downstream pharmaceutical companies in powder form. The production process primarily utilizes the para-aminophenol (PAP) route, characterized by high maturity and controllable costs. Technologically, the industry is moving towards higher purity, lower impurities, and environmentally friendly practices, optimizing synthesis routes and improving process efficiency to achieve a dual optimization of product quality and production costs. Simultaneously, with increasingly stringent global regulations, product consistency and quality standards have become crucial competitive factors.
In terms of the industry chain, upstream suppliers include chemical raw material suppliers such as para-aminophenol and acetic anhydride; midstream are active pharmaceutical ingredient (API) manufacturers; and downstream are pharmaceutical companies and the pharmaceutical distribution system. The industry as a whole exhibits characteristics of large-scale production and a clear global division of labor, with some countries possessing cost and production capacity advantages in API manufacturing. The core of corporate competition lies in production cost control capabilities, quality management systems, and international certification capabilities.
From a regional market perspective, the Asia-Pacific region is the world's main production base for paracetamol APIs, possessing strong cost advantages and export capabilities. North America and Europe hold important positions in pharmaceutical consumption and quality regulation, with stable demand for high-standard APIs. Latin America and Africa have significant potential driven by growing basic healthcare needs. Overall, the global market exhibits a typical active pharmaceutical ingredient (API) pattern of "concentrated production and dispersed consumption."
Looking ahead, the global paracetamol API market will be driven by three core factors: firstly, stable long-term basic medical demand; secondly, increased demand due to population growth and aging; and thirdly, environmental protection and quality regulations driving industry upgrades. The market as a whole will show a development trend of "stable demand + structural optimization," with companies possessing high-quality and highly compliant capabilities gaining more market opportunities.
The global Paracetamol and Acetaminophen API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Paracetamol and Acetaminophen API sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Paracetamol and Acetaminophen API manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Paracetamol and Acetaminophen API product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Paracetamol and Acetaminophen API value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Paracetamol and Acetaminophen API Product Scope
1.2 Paracetamol and Acetaminophen API by Type
1.2.1 Global Paracetamol and Acetaminophen API Sales by Type (2021, 2025 & 2032)
1.2.2 Powder
1.2.3 Granules
1.3 Paracetamol and Acetaminophen API by Application
1.3.1 Global Paracetamol and Acetaminophen API Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Tablet Drug
1.3.3 Granules Drug
1.3.4 Oral Solution
1.3.5 Others
1.4 Global Paracetamol and Acetaminophen API Market Estimates and Forecasts (2021-2032)
1.4.1 Global Paracetamol and Acetaminophen API Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Paracetamol and Acetaminophen API Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Paracetamol and Acetaminophen API Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Paracetamol and Acetaminophen API Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Paracetamol and Acetaminophen API Historical Market Scenario by Region (2021-2026)
2.2.1 Global Paracetamol and Acetaminophen API Sales Market Share by Region (2021-2026)
2.2.2 Global Paracetamol and Acetaminophen API Revenue Market Share by Region (2021-2026)
2.3 Global Paracetamol and Acetaminophen API Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Paracetamol and Acetaminophen API Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Paracetamol and Acetaminophen API Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Paracetamol and Acetaminophen API Market Size and Prospects (2021-2032)
2.4.2 Europe Paracetamol and Acetaminophen API Market Size and Prospects (2021-2032)
2.4.3 China Paracetamol and Acetaminophen API Market Size and Prospects (2021-2032)
2.4.4 India Paracetamol and Acetaminophen API Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Paracetamol and Acetaminophen API Historical Market Review by Type (2021-2026)
3.1.1 Global Paracetamol and Acetaminophen API Sales by Type (2021-2026)
3.1.2 Global Paracetamol and Acetaminophen API Revenue by Type (2021-2026)
3.1.3 Global Paracetamol and Acetaminophen API Average Price by Type (2021-2026)
3.2 Global Paracetamol and Acetaminophen API Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Paracetamol and Acetaminophen API Sales Forecast by Type (2027-2032)
3.2.2 Global Paracetamol and Acetaminophen API Revenue Forecast by Type (2027-2032)
3.2.3 Global Paracetamol and Acetaminophen API Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Paracetamol and Acetaminophen API
4 Global Market Size by Application
4.1 Global Paracetamol and Acetaminophen API Historical Market Review by Application (2021-2026)
4.1.1 Global Paracetamol and Acetaminophen API Sales by Application (2021-2026)
4.1.2 Global Paracetamol and Acetaminophen API Revenue by Application (2021-2026)
4.1.3 Global Paracetamol and Acetaminophen API Average Price by Application (2021-2026)
4.2 Global Paracetamol and Acetaminophen API Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Paracetamol and Acetaminophen API Sales Forecast by Application (2027-2032)
4.2.2 Global Paracetamol and Acetaminophen API Revenue Forecast by Application (2027-2032)
4.2.3 Global Paracetamol and Acetaminophen API Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Paracetamol and Acetaminophen API Applications
5 Competition Landscape by Players
5.1 Global Paracetamol and Acetaminophen API Sales by Player (2021-2026)
5.2 Global Top Paracetamol and Acetaminophen API Players by Revenue (2021-2026)
5.3 Global Paracetamol and Acetaminophen API Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Paracetamol and Acetaminophen API revenue as of 2025
5.4 Global Paracetamol and Acetaminophen API Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Paracetamol and Acetaminophen API, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Paracetamol and Acetaminophen API, Product Type & Application
5.7 Global Key Manufacturers of Paracetamol and Acetaminophen API, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Paracetamol and Acetaminophen API Sales by Company
6.1.1.1 North America Paracetamol and Acetaminophen API Sales by Company (2021-2026)
6.1.1.2 North America Paracetamol and Acetaminophen API Revenue by Company (2021-2026)
6.1.2 North America Paracetamol and Acetaminophen API Sales Breakdown by Type (2021-2026)
6.1.3 North America Paracetamol and Acetaminophen API Sales Breakdown by Application (2021-2026)
6.1.4 North America Paracetamol and Acetaminophen API Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Paracetamol and Acetaminophen API Sales by Company
6.2.1.1 Europe Paracetamol and Acetaminophen API Sales by Company (2021-2026)
6.2.1.2 Europe Paracetamol and Acetaminophen API Revenue by Company (2021-2026)
6.2.2 Europe Paracetamol and Acetaminophen API Sales Breakdown by Type (2021-2026)
6.2.3 Europe Paracetamol and Acetaminophen API Sales Breakdown by Application (2021-2026)
6.2.4 Europe Paracetamol and Acetaminophen API Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Paracetamol and Acetaminophen API Sales by Company
6.3.1.1 China Paracetamol and Acetaminophen API Sales by Company (2021-2026)
6.3.1.2 China Paracetamol and Acetaminophen API Revenue by Company (2021-2026)
6.3.2 China Paracetamol and Acetaminophen API Sales Breakdown by Type (2021-2026)
6.3.3 China Paracetamol and Acetaminophen API Sales Breakdown by Application (2021-2026)
6.3.4 China Paracetamol and Acetaminophen API Major Customers
6.3.5 China Market Trends and Opportunities
6.4 India Market: Players, Segments, Downstream and Major Customers
6.4.1 India Paracetamol and Acetaminophen API Sales by Company
6.4.1.1 India Paracetamol and Acetaminophen API Sales by Company (2021-2026)
6.4.1.2 India Paracetamol and Acetaminophen API Revenue by Company (2021-2026)
6.4.2 India Paracetamol and Acetaminophen API Sales Breakdown by Type (2021-2026)
6.4.3 India Paracetamol and Acetaminophen API Sales Breakdown by Application (2021-2026)
6.4.4 India Paracetamol and Acetaminophen API Major Customers
6.4.5 India Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Mallinckrodt
7.1.1 Mallinckrodt Company Information
7.1.2 Mallinckrodt Business Overview
7.1.3 Mallinckrodt Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Mallinckrodt Paracetamol and Acetaminophen API Products Offered
7.1.5 Mallinckrodt Recent Development
7.2 Anqiu Lu’An Pharmaceutical
7.2.1 Anqiu Lu’An Pharmaceutical Company Information
7.2.2 Anqiu Lu’An Pharmaceutical Business Overview
7.2.3 Anqiu Lu’An Pharmaceutical Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Anqiu Lu’An Pharmaceutical Paracetamol and Acetaminophen API Products Offered
7.2.5 Anqiu Lu’An Pharmaceutical Recent Development
7.3 Granules India
7.3.1 Granules India Company Information
7.3.2 Granules India Business Overview
7.3.3 Granules India Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Granules India Paracetamol and Acetaminophen API Products Offered
7.3.5 Granules India Recent Development
7.4 Farmson
7.4.1 Farmson Company Information
7.4.2 Farmson Business Overview
7.4.3 Farmson Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Farmson Paracetamol and Acetaminophen API Products Offered
7.4.5 Farmson Recent Development
7.5 Hebei Jiheng
7.5.1 Hebei Jiheng Company Information
7.5.2 Hebei Jiheng Business Overview
7.5.3 Hebei Jiheng Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Hebei Jiheng Paracetamol and Acetaminophen API Products Offered
7.5.5 Hebei Jiheng Recent Development
7.6 Zhejiang Kangle Pharmaceutical
7.6.1 Zhejiang Kangle Pharmaceutical Company Information
7.6.2 Zhejiang Kangle Pharmaceutical Business Overview
7.6.3 Zhejiang Kangle Pharmaceutical Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Zhejiang Kangle Pharmaceutical Paracetamol and Acetaminophen API Products Offered
7.6.5 Zhejiang Kangle Pharmaceutical Recent Development
7.7 Sri Krishna Pharmaceuticals
7.7.1 Sri Krishna Pharmaceuticals Company Information
7.7.2 Sri Krishna Pharmaceuticals Business Overview
7.7.3 Sri Krishna Pharmaceuticals Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Sri Krishna Pharmaceuticals Paracetamol and Acetaminophen API Products Offered
7.7.5 Sri Krishna Pharmaceuticals Recent Development
7.8 Anhui Fengyuan Pharmaceutical
7.8.1 Anhui Fengyuan Pharmaceutical Company Information
7.8.2 Anhui Fengyuan Pharmaceutical Business Overview
7.8.3 Anhui Fengyuan Pharmaceutical Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Anhui Fengyuan Pharmaceutical Paracetamol and Acetaminophen API Products Offered
7.8.5 Anhui Fengyuan Pharmaceutical Recent Development
7.9 Seqens
7.9.1 Seqens Company Information
7.9.2 Seqens Business Overview
7.9.3 Seqens Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Seqens Paracetamol and Acetaminophen API Products Offered
7.9.5 Seqens Recent Development
7.10 Atabay Ilaç Fabrikasi
7.10.1 Atabay Ilaç Fabrikasi Company Information
7.10.2 Atabay Ilaç Fabrikasi Business Overview
7.10.3 Atabay Ilaç Fabrikasi Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Atabay Ilaç Fabrikasi Paracetamol and Acetaminophen API Products Offered
7.10.5 Atabay Ilaç Fabrikasi Recent Development
7.11 Anhui Fubore Pharmaceutical
7.11.1 Anhui Fubore Pharmaceutical Company Information
7.11.2 Anhui Fubore Pharmaceutical Business Overview
7.11.3 Anhui Fubore Pharmaceutical Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Anhui Fubore Pharmaceutical Paracetamol and Acetaminophen API Products Offered
7.11.5 Anhui Fubore Pharmaceutical Recent Development
8 Paracetamol and Acetaminophen API Manufacturing Cost Analysis
8.1 Paracetamol and Acetaminophen API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Paracetamol and Acetaminophen API
8.4 Paracetamol and Acetaminophen API Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Paracetamol and Acetaminophen API Distributors List
9.3 Paracetamol and Acetaminophen API Customers
10 Paracetamol and Acetaminophen API Market Dynamics
10.1 Paracetamol and Acetaminophen API Industry Trends
10.2 Paracetamol and Acetaminophen API Market Drivers
10.3 Paracetamol and Acetaminophen API Market Challenges
10.4 Paracetamol and Acetaminophen API Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Paracetamol and Acetaminophen API was estimated to be worth US$ 962 million in 2025 and is projected to reach US$ 1065 million, growing at a CAGR of 1.5% from 2026 to 2032.
Published Date: 2026-04-16
Pages: 137
USD 3950.00
(Single User License)
The global Paracetamol and Acetaminophen API market was valued at US$ 962 million in 2025 and is anticipated to reach US$ 1065 million by 2032, at a CAGR of 1.5% from 2026 to 2032.
Published Date: 2026-04-16
Pages: 138
USD 2900.00
(Single User License)
The global Paracetamol and Acetaminophen API market is projected to grow from US$ 962 million in 2025 to US$ 1065 million by 2032, at a CAGR of 1.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-04-16
Pages: 156
USD 4900.00
(Single User License)
The global Paracetamol and Acetaminophen API market size was US$ 1389 million in 2024 and is forecast to a readjusted size of US$ 1647 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 97
USD 4250.00
(Single User License)
The global Paracetamol and Acetaminophen API market is projected to grow from US$ 1389 million in 2024 to US$ 1647 million by 2031, at a CAGR of 2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 166
USD 4900.00
(Single User License)
The global market for Paracetamol and Acetaminophen API was valued at US$ 1389 million in the year 2024 and is projected to reach a revised size of US$ 1647 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published Date: 2025-01-16
Pages: 97
USD 2900.00
(Single User License)
The global market for Paracetamol and Acetaminophen API was estimated to be worth US$ 1389 million in 2024 and is forecast to a readjusted size of US$ 1647 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 127
USD 3950.00
(Single User License)
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published Date: 2024-04-12
Pages: 110
USD 4900.00
(Single User License)
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published Date: 2024-01-12
Pages: 96
USD 2900.00
(Single User License)
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published Date: 2024-01-08
Pages: 127
USD 3950.00
(Single User License)
The global market for Paracetamol and Acetaminophen API was estimated to be worth US$ 962 million in 2025 and is projected to reach US$ 1065 million, growing at a CAGR of 1.5% from 2026 to 2032.
Published: 2026-04-16
Pages: 137
The global Paracetamol and Acetaminophen API market was valued at US$ 962 million in 2025 and is anticipated to reach US$ 1065 million by 2032, at a CAGR of 1.5% from 2026 to 2032.
Published: 2026-04-16
Pages: 138
The global Paracetamol and Acetaminophen API market is projected to grow from US$ 962 million in 2025 to US$ 1065 million by 2032, at a CAGR of 1.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-04-16
Pages: 156
The global Paracetamol and Acetaminophen API market size was US$ 1389 million in 2024 and is forecast to a readjusted size of US$ 1647 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 97
The global Paracetamol and Acetaminophen API market is projected to grow from US$ 1389 million in 2024 to US$ 1647 million by 2031, at a CAGR of 2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 166
The global market for Paracetamol and Acetaminophen API was valued at US$ 1389 million in the year 2024 and is projected to reach a revised size of US$ 1647 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published: 2025-01-16
Pages: 97
The global market for Paracetamol and Acetaminophen API was estimated to be worth US$ 1389 million in 2024 and is forecast to a readjusted size of US$ 1647 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 127
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published: 2024-04-12
Pages: 110
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published: 2024-01-12
Pages: 96
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published: 2024-01-08
Pages: 127
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now